Alexion Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 57
- Published: May 2019
- Report Code: MLPH66520FSA
Alexion Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic diseases, cancer, neurological and autoimmune disorders. The company’s marketed product portfolio includes Ultomiris for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); Soliris (eculizumab) used for two indications paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (AHUS); Strensiq (asfotase alfa) for the treatment of hypophosphatasia (HPP) and Kanuma (sebelipase alfa) for the treatment of Lysosomal Acid Lipase Deficiency (LAL Deficiency or LAL-D). Alexion is headquartered in New Haven, Connecticut, the US.
Scope
Detailed information on Alexion Pharmaceuticals Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Alexion Pharmaceuticals Inc in the form of a SWOT analysis
An in-depth view of the business model of Alexion Pharmaceuticals Inc including a breakdown and examination of key business segments
News about Alexion Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Alexion Pharmaceuticals Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Alexion Pharmaceuticals Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Alexion Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Omeros Corp
Ligand Pharmaceuticals Inc
Genzyme Corp
Dart NeuroScience LLC
Baxter International Inc
Amgen Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.